Elevated CSF prostaglandin E2 levels in patients with probable AD

Neurology

Volumn 53, Issue 7, 1999, Pages 1495-1498

  Montine, T J ^a,b   Sidell, K R ^b   Crews, B C ^a   Markesbery, W R ^c   Marnett, L J ^a,b   Roberts II, L J ^a,b   Morrow, J D ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

AD; CSF; Cyclo oxygenase; Prostaglandins

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN D; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE B2;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0032740467     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.7.1495     Document Type: Article

References (21)

1. McGeer PL, Schulzer M, McGeer E. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies. Neurology 1996;47:425-432.
2. Pasinetti GM. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res 1998;54:1-6.
3. Siedlik PH, Marnett LJ. Oxidizing radical generation by prostaglandin H synthase. Methods Enzymol 1984;105:412-416.
4. Kaufmann WE, Andreasson KI, Isakson PC, Worley PF. Cyclooxygenases and the central nervous system. Prostaglandins 1997;54:601-624.
5. Lukiw WJ, Bazan NG. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer's neocortex. J Neurosci Res 1997;50:937-945.
6. Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998;87:319-324.
7. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
8. DuBois RN, Awad J, Morrow JD, Roberts LJ II, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest 1994;93:493-498.
9. 2-isoprostanes produced by non-cyclooxygenase free radical catalyzed mechanism. Methods Enzymol 1994;233:163-174.
10. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
11. Romero SD, Chyatte D, Byer DE, Romero JC, Yaksh TL. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man. J Neurochem 1984;43:1642-1649.
12. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
13. 2-isoprostane concentration in probable Alzheimer's disease. Neurology 1999;52:562-565.
14. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin synthesis. Proc Natl Acad Sci USA 1996;93:15069-15074.
15. Slepko N, Levi G. Progressive activation of adult microglial cells in vitro. Glia 1996;16:241-246.
16. Carpenter AF, Carpenter PW, Markesbery WR. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 1993;52:601-608.
17. Lazarewicz JW, Salinska E. N-methyl-D-aspartate-evoked release of cyclooxygenase products in rabbit hippocampus: an in vivo microdialysis study. J Neurochem Res 1995;40:660-666.
18. 2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants. J Neurosci 1999;19:940-947.
19. Kolko M, DeCoster A, Rodriguez deTurco EB, Bazan NG. Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem 1996;271:32722-32728.
20. 2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease. Biochem Biophys Res Commun 1998; 249:182-186.
21. Griffin DE, Wesselingh SL, McArthur JC. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 1994;35:592-597.